Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase II.

Tatsiana YarashImrana SharifFarhat MasoodRhonda M CliffordWendy A Davis Timothy M E Davis

Published in: Internal medicine journal (2021)

CM use in type 2 diabetes is both common and costly. Healthcare professionals should consider discussing safe and cost-effective use of CM with their patients with type 2 diabetes.

Keyphrases

type diabetes
phase ii
clinical trial
glycemic control
open label
cardiovascular disease
insulin resistance
randomized controlled trial
placebo controlled
weight loss